The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma.
about
The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infectionHuman papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitorQuantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwashThe synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cellsHerpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.SLPI and AnxA2 expression in neoplasm-free palatine tonsils is associated with smoking habit of individuals.Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients.A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease.Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesions.Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers.miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI.Smoking-Induced SLPI Expression Hinders HPV Infections Also in Squamous Cell Carcinomas of the Vulva
P2860
Q21134079-11275FF6-6BB3-470E-8A60-0A50C2437C81Q28286766-1A2174C9-9937-4C00-ABB7-B83CE15045E8Q28300527-BAB491A1-9200-4C2E-84B6-3F2FFA2791CFQ28483778-D6328F3B-EE2A-4D80-87FA-9DB799C7F858Q36720700-30A3F6F2-900F-47F7-8DE0-16E0FB395835Q36731195-B369C178-548A-40AA-90DE-C2A791C37FB5Q38622805-7FD864B5-FA55-4C85-8E6A-78AD4A2CCFFDQ39547383-2F04FE78-1721-4140-A303-FF629958ECD1Q40686286-AEC73EB2-BA2A-4C91-89F3-89794B1A7D5BQ41960978-8A9AD622-406F-4448-BDAC-1528F9E0222FQ45934714-01D4CBAB-D6D3-43E6-BC34-410FABA7D586Q47220626-6F30DCDE-9659-4FD4-9AC8-B9CC8581B6A8Q47359848-52F52305-57B8-483A-B172-11C568A263C9Q57149787-97A9121C-2FF8-4D57-AFA6-5C1E145F4574
P2860
The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The level of secretory leukocy ...... neck squamous cell carcinoma.
@ast
The level of secretory leukocy ...... neck squamous cell carcinoma.
@en
The level of secretory leukocy ...... neck squamous cell carcinoma.
@nl
type
label
The level of secretory leukocy ...... neck squamous cell carcinoma.
@ast
The level of secretory leukocy ...... neck squamous cell carcinoma.
@en
The level of secretory leukocy ...... neck squamous cell carcinoma.
@nl
prefLabel
The level of secretory leukocy ...... neck squamous cell carcinoma.
@ast
The level of secretory leukocy ...... neck squamous cell carcinoma.
@en
The level of secretory leukocy ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
The level of secretory leukocy ...... neck squamous cell carcinoma.
@en
P2093
Christian Cordes
Christian Werner
Lena Hebebrand
Markus Hoffmann
Petra Ambrosch
Robert Häsler
Stefan Schreiber
Tibor Görögh
W Martin Kast
P2860
P304
P356
10.3892/IJO.2011.1006
P577
2011-04-14T00:00:00Z